Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Italy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Melanoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Mattia Altini

Mattia Altini

Person: Academic

20052018
No photo of Dino Amadori

Dino Amadori

Person: Academic

19682018
No photo of Daniele Andreis

Daniele Andreis

Person: Academic

20112017

Projects 2018 2018

Istituto Scientifico Romagnolo - GENETICA E AMBIENTE NELLO SVILUPPO E PROGRESSIONE DEI TUMORI E MECCANISMI INIBITORI. EXPOSOMICA, PREVENZIONE PRIMARIA E SECONDARIA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Istituto Scientifico Romagnolo - TERAPIE INNOVATIVE, TRIALS DI FASE I-III E DI STRATEGIA TERAPEUTICA BASATI SU MODELLI PRECLINICI, MECCANISMI ONCO-IMMUNOLOGICI, NANOVETTORI

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Istituto Scientifico Romagnolo - APPROPRIATEZZA, ESITI, VALUE DEL FARMACO E MODELLI ORGANIZZATIVI FUNZIONALI ALLA CONTINUITA' DEI PERCORSI DIAGNOSTICO-TERAPEUTICI IN ONCOLOGIA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Research Output 1965 2018

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A. & 12 othersPronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R. & Guarneri, V., Sep 13 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology.

Research output: Contribution to journal › Article

Combination Drug Therapy
Disease-Free Survival
Bayes Theorem
Breast Neoplasms
Drug Therapy

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

NEPscore Working Group, Jun 1 2018, In : Endocrine-Related Cancer. 25, 6, p. 607-618 12 p.

Research output: Contribution to journal › Article

Neuroendocrine Tumors
Survival
Italy
Calibration
Databases
5 Citations

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

GIM Investigators, Apr 1 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journal › Article

exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms